MEDICAL TRANSCRIPTION BILLING, CORP.

7 Clyde Road

Somerset, New Jersey 08873

July 12, 2017

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, DC 20549

Ladies and Gentlemen:

Medical Transcription Billing, Corp., a Delaware corporation (the “Company”), hereby undertakes to promptly file a post-effective amendment to its Registration Statement on Form S-1 (File No. 333-214863) to deregister all of the shares registered thereunder that were not sold by the Company it is recently completed offering of its Series A Preferred Stock.

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the Company hereby requests that the effective date for the above captioned Registration Statement (File No.: 333-219122) be accelerated so that it will be declared effective on July 13, 2017 at 4:00 p.m., Eastern time, or as soon thereafter as practicable. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

The Company requests that it be notified of such effectiveness by a telephone call to Mr. David Song, of Mazzeo Song P.C., at (212) 599-3077, or, in his absence, to Ms. Shruti Patel, the Company’s general counsel, at (732) 873-5133 x146.